Polymer Capital Management (Hk) LTD Nurix Therapeutics, Inc. Transaction History
Polymer Capital Management (Hk) LTD
- $725 Billion
- Q3 2025
A detailed history of Polymer Capital Management (Hk) LTD transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Polymer Capital Management (Hk) LTD holds 58,898 shares of NRIX stock, worth $753,894. This represents 0.08% of its overall portfolio holdings.
Number of Shares
58,898
Previous 58,898
-0.0%
Holding current value
$753,894
Previous $671 Million
18.88%
% of portfolio
0.08%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding NRIX
# of Institutions
184Shares Held
77.6MCall Options Held
99.8KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$87.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.06MShares$77.5 Million1.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.49MShares$57.5 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$49.7 Million0.29% of portfolio
-
Commodore Capital LP New York, NY3.78MShares$48.4 Million2.23% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $603M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...